The Lazard Global Medical Devices, Diagnostics and Tools Leaders Study 2023 is a comprehensive analysis of the medical devices, diagnostics, and tools industry. The study found that the industry is undergoing a period of transformation, driven by rapid technological innovation and a need for greater product affordability. The integration of artificial intelligence, robotics, and data analytics in device design and manufacturing, as well as the increasing use of multi-omics tools, declining sequencing costs, and scaling of bioinformatics in diagnostics and tools, are poised to transform both spaces in the next five to ten years. Market participants must navigate challenges such as stricter regulatory frameworks, data privacy concerns, and reimbursement challenges, while embracing digital transformation and fostering innovation to remain competitive. Public financing markets remain challenging as investors focus on pathways to profitability. M&A activity has been limited as consolidators face macroeconomic uncertainty, experience valuation mismatches with seller price expectations, and struggle to find targets that meet their strategic priorities.
